Status:
COMPLETED
Implantable Cardioverter-Defibrillator Use in the VA System
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Medtronic
VA Palo Alto Health Care System
Conditions:
Cardiomyopathies
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Despite being a proven life-saving intervention in appropriately selected individuals, multiple studies continue to demonstrate low implantation of defibrillators in potential candidates. Based upon p...
Eligibility Criteria
Inclusion
- Meeting published criteria for receipt of an implantable cardioverter defibrillator
Exclusion
- provider is not affiliated with the VA health care system
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
89 Patients enrolled
Trial Details
Trial ID
NCT01217827
Start Date
April 1 2010
End Date
December 1 2013
Last Update
May 19 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
VA Palo Alto Health Care System
Palo Alto, California, United States, 94304
2
Stanford University School of Medicine
Stanford, California, United States, 94305